首页 › 小细胞肺癌 › 纽约州 › New York City
New York City NY 小细胞肺癌临床试验
22项针对 小细胞肺癌的研究正在 New York City及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
招募中1 期
- Memorial Sloan Kettering Cancer Center, New York
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
招募中1/2 期
- Columbia University Medical Center, New York
- Memorial Sloan Kettering, New York
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
招募中2 期
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Memorial Sloan Kettering Cancer Center, New York
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
招募中1 期
- Memorial Sloan Kettering Cancer Center Head Neck Services, New York
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
招募中1/2 期
- Avenzo Therapeutics Recruiting Site, New York
A Study of Armored CAR T Cells in People With Cancer
招募中1 期
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
招募中3 期
- Cornell University - NewYork-Presbyterian/Weill Cornell Medical Center, New York
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
招募中1/2 期
- Memorial Sloan Kettering, New York
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
招募中1/2 期
- Memorial Sloan Kettering Cancer Center (MSKCC), New York
- Icahn School of Medicine at Mount Sinai PRIME, New York
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
招募中1 期
- NYU Langone Health, New York
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
招募中1 期
- New York University Cancer Institute, New York
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
招募中1/2 期
- Memorial Sloan Kettering Cancer Center, New York
A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer
招募中1 期
- Memorial Sloan Kettering Cancer Center, New York
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
招募中3 期
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health Long Island, New York
- New York University Cancer Center - Laura and Isaac, New York
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
招募中1/2 期
- Columbia University Medical Center - Herbert Irving Pavilion, New York
A Study of LY4175408 in Participants With Advanced Cancer
招募中1 期
- Columbia University, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of Hospital-at-Home for People Receiving Tarlatamab
招募中
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
招募中2 期
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Lung Cancer Biomarkers and Screening
招募中观察性研究欢迎健康志愿者
- NYU Cancer Institute at New York University Medical Center, New York
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
招募中1/2 期
- Weill Cornell Medicine, Cornell University (site 126), New York
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
招募中1/2 期
- Research Site 107, New York
Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)
招募中观察性研究
- Icahn School of Medicine at Mount Sinai, New York
其他城市的 小细胞肺癌试验
- Houston, TX26 项研究
- Arlington, VA23 项研究
- Boston, MA21 项研究
- Los Angeles, CA20 项研究
- Nashville, TN20 项研究
- Orlando, FL15 项研究
- Dallas, TX13 项研究
- Cleveland, OH13 项研究
- Chicago, IL13 项研究
- St. Louis, MO13 项研究
- Detroit, MI12 项研究
- Washington, DC12 项研究
New York City的其他研究
- 乳腺癌136 项研究
- 非小细胞肺癌121 项研究
- 癌症（所有类型）109 项研究
- 前列腺癌103 项研究
- 转移性癌症93 项研究
- 结直肠癌78 项研究
- 卵巢癌69 项研究
- 肺癌60 项研究
- 多发性骨髓瘤60 项研究
- 胰腺癌60 项研究
- 子宫内膜癌52 项研究
- 急性髓系白血病51 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。